Acute myocardial infarction complicated by ventricular standstill terminated by thrombolysis and transcutaneous

Nick Castle1, Crispin Porter, Beverley Thompson

  • 1Department of EMC&R, Durban University of Technology, South Africa. Nicholas.castle@ntlworld.com

Resuscitation
|April 10, 2007
PubMed

Insights

Transcutaneous pacing provides a non-invasive emergency strategy to optimize circulation after acute myocardial infarction (AMI) complicated by heart block or ventricular standstill. It also enables safe thrombolytic therapy for reperfusion.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Critical Care

Background:

  • The advent of thrombolysis has decreased the need for emergency pacing post-acute myocardial infarction (AMI).
  • However, certain complications like complete heart block (CHB) or ventricular standstill still necessitate urgent circulatory support.
  • Transcutaneous pacing offers a readily available, non-invasive method for such critical situations.

Observation:

  • Transcutaneous pacing serves as an immediate intervention to stabilize hemodynamics in AMI patients with conduction abnormalities.
  • This technique allows for effective management without requiring invasive procedures.
  • It directly addresses the compromised cardiac output during these emergencies.

Findings:

  • Transcutaneous pacing is a viable emergency strategy for optimizing circulation in cases of CHB or ventricular standstill post-AMI.
  • The use of transcutaneous pacing facilitates the timely and safe administration of thrombolytic agents.
  • This approach aids in achieving reperfusion of the cardiac conduction system, crucial for recovery.

Implications:

  • This highlights the continued importance of transcutaneous pacing as a critical tool in the emergency management of AMI.
  • It underscores its role in enabling potentially life-saving thrombolytic therapies.
  • The findings support the integration of transcutaneous pacing protocols in emergency cardiac care pathways.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...